For example, in 2017, one published study demonstrated that GPER activation by its specific agonist G-1 in CRC cell lines (HCT116 and SW480 cells) inhibited cell growth and promoted tumor cell apoptosis (102). Here, GPER1 is linked to colorectal carcinoma.